本页面由Tiger Trade Technology Pte. Ltd.提供服务

Castle Biosciences, Inc.

23.53
-1.1700-4.74%
盘后23.530.00000.00%18:46 EDT
成交量:29.41万
成交额:701.00万
市值:7.00亿
市盈率:-28.23
高:24.65
开:24.60
低:23.44
收:24.70
52周最高:44.28
52周最低:14.59
股本:2,973.12万
流通股本:2,511.27万
量比:0.97
换手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-0.8334
每股收益(LYR):-0.8334
净资产收益率:-5.21%
总资产收益率:-2.56%
市净率:1.49
市盈率(LYR):-28.23

数据加载中...

2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities